8 Results for "

PDL1 degrader-2

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "PDL1 degrader-2" in MCE Product Catalog:

Cat. No.: HY-169363
Research Areas:  

Cancer

PD-L1 degrader-2 (Compound B3) is an orally active AUTAC degrader, that degrades PD-L1 through autophagy-lysosome pathway with a DC50 of 0.5 μM. PD-L1 degrader-2 exhibits inhibitory activity against PD-1/PD-L1 interaction with an IC50 of 22.8 nM. PD-L1 degrader-2 upregulates the expressions of Atg9b, Lamp1 and Mitf, and activates the autophagy lysosome system. PD-L1 degrader- exhibits antitumor efficacy in CT26 mouse model [1]. (Pink: autophagy-lysosome activator (HY-159894); Black: linker (HY-W015088); Blue: PD-L1 ligand (HY-169365))
loading...
    loading...
Cat. No.: HY-162972
CAS No.: 2995357-09-8
Target:  

PROTACs PD-1/PD-L1

Research Areas:  

Inflammation/Immunology Cancer

PROTAC PD-L1 degrader-2 is a PD-L1 PROTAC degrader with an IC50 of 197.4 nM and a Kd of 301 nM. PROTAC PD-L1 degrader-2 induces PD-L1 endocytosis, drives degradation via the proteasomal and lysosomal pathways, and inhibits the PD-1/PD-L1 interaction. As an immune activator, PROTAC PD-L1 degrader-2 increases the levels of CD4 +, CD8 +, granzyme B and perforin. PROTAC PD-L1 degrader-2 can be used in studies related to colon cancer immunology [1].
loading...
    loading...
Cat. No.: HY-169365
CAS No.: 2766689-18-1
Research Areas:  

Cancer

2-Methylbiphenyl-oxadiazole-NH-Ph-CHO is a PD-L1 ligand. 2-Methylbiphenyl-oxadiazole-NH-Ph-CHO serves as the PD-L1 ligand of AUTAC PDL1 degrader-2 (HY-169363). 2-Methylbiphenyl-oxadiazole-NH-Ph-CHO activates the autophagy-lysosome system and upregulates autophagy-lysosome-related genes. 2-Methylbiphenyl-oxadiazole-NH-Ph-CHO is applicable for cancer research [1].
loading...
    loading...
Cat. No.: HY-162841
Research Areas:  

Cancer

HPK1 ligand 1 is a PROTAC target protein ligand (Ligands for Target Protein for PROTACs). HPK1 ligand 1 can be used for synthesis PROTAC PD-L1 degrader-2 (HY-162816) [1].
loading...
    loading...
Cat. No.: HY-162840
CAS No.: 2770869-33-3
Research Areas:  

Cancer

Thalidomide-azetidin-3-one is an E3 Ligase Ligand-Linker Conjugate. Thalidomide-azetidin-3-one can be used to synthesize PROTAC PD-L1 degrader-2 (HY-162816) [1].
loading...
    loading...
Cat. No.: HY-169364
Target:  

AUTACs PD-1/PD-L1

Research Areas:  

Cancer

2-Methylbiphenyl-oxadiazole-NH-Ph-NH-PEG3-C2-NH-Boc serves as the PD-L1 ligand-linker conjugate of AUTAC PDL1 degrader-2 (HY-169363). 2-Methylbiphenyl-oxadiazole-NH-Ph-NH-PEG3-C2-NH-Boc is applicable to AUTAC synthesis. It is also used in the research of colorectal cancer [1].
loading...
    loading...
Cat. No.: HY-182959
Hsp70TAC PD-1 Degrader-2 is a PD-L1 Hsp70TAC (Hsp70-targeting Chimeras) degrader with Kd values of 0.36 μM. Hsp70TAC PD-1 Degrader-2 forms a ternary complex with Hsp70 and PD-L1 to drive PD-L1 degradation. Hsp70TAC PD-1 Degrader-2 induces degradation of mature membrane-bound PD-L1 in an Hsp70-dependent manner and via caveolin-mediated endocytosis and lysosomal trafficking. Hsp70TAC PD-1 Degrader-2 accumulates preferentially in tumor cells with elevated Hsp70 expression for tumor-selective PD-L1 degradation. Hsp70TAC PD-1 Degrader-2 can be used for the research of cancer, such as breast invasive carcinoma, glioblastoma multiforme, diffuse large b-cell lymphoma [1]. (Pink: PD-1/PD-L1 ligand (HY-19745A); Blue: Hsp70 ligand (HY-182979); Black: linker (HY-182982)).
loading...
    loading...
Cat. No.: HY-162842
Research Areas:  

Cancer

HPK1-IN-51 is a PROTAC target protein ligand (Ligands for Target Protein for PROTACs). HPK1-IN-51 can be used for synthesis PROTAC PD-L1 degrader-2 (HY-162816) [1].
loading...
    loading...